Cohance Lifesciences Ltd
₹311.95
(3.48%)
Tue, 07 Apr 2026, 01:04 pm
Health Technology
Pharmaceuticals: Major
24.5KCohance Lifesciences Share Price Live Chart
1 Day
0 (0%)
No Result Found
Summary
Market Cap
11553.53
Net Profit
264.77
P/B
17.40
Sector P/E
31.02
P/E
110.25
EV/EBITDA
68.51
Debt/Equity (Industry)
0.23
Interest Cover (Industry)
9.71
ROCE (Industry)
13
RONW (Industry)
12.31
ROE
12.50
ROCE
13.56
Debt/Equity
0.09
EPS (TTM)
7.86
Dividend Yield
0
Book Value
99.01
Interest Cover
25.54
Analysis
all
- Suven Pharmaceuticals has no long term commitments.
- Low level of unsold assets.
- Unable to evaluate Suven Pharmaceuticals's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Suven Pharmaceuticals's dividend against the top 25% market benchmark as the company has not reported any payouts.
- Suven Pharmaceuticals's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
- Operating cash flow is negative therefore debt is not well covered.
- Suven Pharmaceuticals has negative shareholder equity (liabilities exceed assets) therefore debt is not covered by short term assets.
Shareholding
| Shareholders | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 | DEC 2024 |
|---|---|---|---|---|---|
| Promoters | 57.49 | 57.49 | 66.41 | 50.10 | 50.10 |
| FII | 6.02 | 6.51 | 7.23 | 11.05 | 10.84 |
| DII | 21.57 | 20.82 | 11.40 | 16.60 | 16.68 |
| Public | 14.92 | 15.17 | 14.95 | 22.23 | 22.37 |
| Government | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 386.08 | 339.88 | 320.67 | 293.68 | 274.47 | 247.48 | 201.28 |
| Fibonacci | 339.88 | 322.23 | 311.33 | 293.68 | 276.03 | 265.13 | 247.48 |
| Camarilla | 314.15 | 309.92 | 305.69 | 293.68 | 297.21 | 292.98 | 288.75 |
Pivots Level: Classic
R3
+92.40
386.08
R2
+46.20
339.88
R1
+26.98
320.67
S1
-19.22
274.47
S2
-46.20
247.48
S3
-92.40
201.28
Moving Average
Period
Value
10-EMA
302.67
20-EMA
304.37
30-EMA
312.74
50-EMA
343.29
100-EMA
445.08
200-EMA
609.01
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 12 Feb 2026 | board-meetings | Quarterly Results | |
| 12 Nov 2025 | board-meetings | Quarterly Results | |
| 26 Jun 2025 | agm | ||
| 29 Oct 2024 | egm | ||
| 13 Jul 2024 | agm | ||
| 06 Jul 2024 | agm | Annual General Meeting | 07 Aug 2024 |
| 12 Nov 2023 | agm | Annual General Meeting | 13 Dec 2023 |
| 09 Nov 2023 | agm | ||
| 02 Sept 2022 | dividend | ₹1.00 Dividend /Share | 12 Sept 2022 |
| 12 Aug 2022 | dividend | Special Dividend - Rs. - 5 | 12 Sept 2022 |
Peer Comparison
Cohance Lifesciences Ltd
Torrent Pharmaceuticals Ltd
Sun Pharmaceutical Industries Ltd
Divis Laboratories Ltd
Dr Reddys Laboratories Ltd
Lupin Ltd
Cohance Lifesciences Ltd About
Cohance Lifesciences is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Specialty Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology and chemical companies.
Industry
Pharmaceuticals - Indian - Bulk Drugs & Formln
Founded
2018
Headquarters
CEO
Vivek Sharma
Employees
Contact
Website
http://www.suvenpharm.com
khrao@suvenpharm.com
Phone
91-40-23549414/1142/3311
Location
8-2-334 SDE Serene Chambers, 3 Floor Avenue 7 Road No 5, Hyderabad, Telangana, 500034
Cohance Lifesciences Ltd Company History
| Year | History |
|---|---|
| 2018 |
|
| 2020 |
|
| 2021 |
|
| 2022 |
|
Deals
| Client Name | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|
| JASUB PROPERTY HOLDINGS LLP | Buy | 7700000 | 306 | 23 Feb 2026 |
| JASTI FAMILY TRUST | Sell | 7700000 | 306 | 23 Feb 2026 |
| JASTI FAMILY TRUST | Sell | 7000000 | 309 | 18 Feb 2026 |
| JASUB PROPERTY HOLDINGS LLP | Buy | 7000000 | 309 | 18 Feb 2026 |
| HDFC MUTUAL FUND | Buy | 3717650 | 906 | 18 Sept 2025 |
| JUSMIRAL HOLDINGS LIMITED | Sell | 34148000 | 906 | 18 Sept 2025 |
| SBI MUTUAL FUND | Buy | 2683278 | 905.71 | 18 Sept 2025 |
| ABU DHABI INVESTMENT AUTHORITY STABLE | Buy | 1574000 | 698.15 | 01 Mar 2024 |
| AMANSA HOLDINGS PRIVATE LIMITED | Sell | 3126653 | 689.19 | 01 Mar 2024 |
| RAMBABU CHIRUMAMILLA | Sell | 3808386 | 530.68 | 14 Sept 2023 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800